- Merck KGaA is rumored to be on the verge of acquiring the UK company Seven Seas, which manufactures vitamin supplements. Reports from sources "close to the talks" are suggesting that "the deal is 95% there." This has not been confirmed by Merck KGaA or Hanson of the UK, Seven Seas' parent company. Merck KGaA is looking to improve its position in the over-the-counter market, and recently acquired Laboratoires Monot of France (Marketletter April 1) from Cofige Holdings. Self-medication currently accounts for 13% of total pharmaceutical sales in Europe at Merck, and is believed to have the potential to reach 25%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze